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Abstract 
Ståhl,  Karl.  2006.  Bovine  Viral  Diarrhoea  Virus  and  Other  Reproductive  Pathogens-
Epidemiological Studies in Peruvian Cattle. Doctoral thesis 
ISSN 1652-6880, ISBN 91-576-7102-8 
 
This thesis deals with aspects of the epidemiology of bovine viral diarrhoea virus (BVDV) 
of relevance to control, with particular focus on the situation in Peruvian smallholder dairy 
farms.  In addition,  the importance of Neospora caninum  and bovine herpesvirus  type 1 
(BHV-1) is addressed, as these are important differential diagnoses to BVDV.  
The prevalence of BVDV and BHV-1 was studied in smallholder dairy farms in a rural 
area.  Using  bulk  tank  milk  testing  for  detection  of  antibodies  it  was  shown  that  the 
prevalence of active BVDV infection was low, and that a large proportion of the herds were 
free from BHV-1. A study of the BVDV situation in the major dairy region in the country 
demonstrated a very high level of exposure to BVDV. Individual testing of young stock 
indicated, however, that many herds might be cleared from BVDV without intervention, 
and that a long-term reduction in prevalence can be achieved as long as adequate attention is 
given to systematic measures aimed at preventing re-introduction of infection. 
An endemic abortion problem in a dairy herd with concurrent infections with Neospora 
caninum and BVDV was investigated. Using a prospective seroepidemiological approach it 
was possible to estimate the magnitude of associations between the infections and risk of 
abortion, and to demonstrate that Neospora caninum infection significantly affected the risk 
within the herd. Evidence of active BVDV infection, on the other hand, was not associated 
with abortions. 
The phylogenetic analysis of BVDV strains isolated from animals detected as persistently 
infected, demonstrated that all belonged to genotype 1, subtype 1b. The genetic similarity 
with previously described strains reflected the role of livestock trade for the diversity of 
BVDV.  Imported  livestock  is  the  probable  source  of  BVDV  strains  circulating  in  the 
country, and this was supported by the phylogenetic analysis. 
Finally, it was demonstrated that a molecular epidemiological approach might be used to 
trace routes of transmission, and to identify and prevent risky behaviour.  
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Resumen 
Ståhl, Karl. 2006. La Diarrea Viral Bovina  y Otros Patógenos  Que Afectan al Sistema 
Reproductivo – Estudios epidemiológicos en el Perú.. Tesis doctoral. 
ISSN 1652-6880, ISBN 91-576-7102-8 
 
Esta  tésis  trata  aspectos  epidemiológicos  del  virus  de  la  diarrea  viral  bovina  (BVDV) 
relevantes para su control y particularmente en la situación de pequeñas granjas lecheras del 
país. Se incluye además la importancia de Neospora caninum y del herpesvirus bovino tipo 
1 (BHV-1) como patógenos de importancia diagnóstica diferencial. 
Utilizando leche de tanque para detectar anticuerpos contra BVDV y BHV-1, se estudió 
su prevalencia en animals de areas rurales. Se constató una prevalencia baja de infección 
activa con BVDV y que una gran parte de los hatos estaban libres de BHV-1. Un estudio de 
la situación de BVDV en la region lechera mas grande del país, demostró por su parte un 
alto  indice  de  exposición  a  BVDV.  Pruebas  individuales  en  animals  jóvenes  indicaron 
sinembargo,  que  BVDV  se  habrá  eliminado  sin  necesidad  alguna  de  aplicar  medidas 
especiales y que una disminución de la prevalencia de la enfermedad a largo plazo, puede 
lograrse si se aplican medidas sistemáticas con el objeto de evitar la re-introducción de la 
infección. 
Se investigó un problema de abortos endémicos en un hato lechero, con infección doble 
de Neospora caninum y BVDV. Mediante un estudio sero-epidemiológico prospectivo fué 
posible estimar la magnitud de asociación de esta doble infección y riezgo de abortos y se 
demostró así mismo que una infección con Neospora caninum afecta significativamente el 
riezgo dentro de un hato. Sinembargo no se evidenció en este estudio una asociación de una 
infección activa con BVDV y abortos.  
Un análisis filogénico de cepas de BVDV aisladas de animales con infección persistente, 
demostró que el virus pertenece al genotipo 1, subtipo 1b. La similitud genética con cepas 
antes descritas en otros paises, refleja el papel del comercio de ganado para la diversidad de 
BVDV. Animales importados son la causa probable de la circulación de cepas del virus en 
el pais. Esto fué corroborado por el análisis filogénico. 
Finalmente, se demostró que un estudio de epidemiología molecular podría ser utilizado 
para identificar las rutas de transmisión e identificar y prevenir los posibles riezgos. 
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Papers I-V 
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Preventive Veterinary Medicine (In print). 
 
IV. Ståhl K., Benito A., Felmer R., Zuñiga J., Reinhardt G., Rivera H., Baule C., 
and Moreno-Lopéz J. Genetic diversity of BVDV isolates from Peru and Chile. 
(Manuscript). 
 
V.  Ståhl  K.,  Kampa  J.,  Baule  C.,  Isaksson  M.,  Moreno-López  J.,  Belak  S., 
Alenius  S.,  and  Lindberg  A.  (2005).  Molecular  epidemiology  of  Bovine  Viral 
Diarrhoea  during  the  final  phase  of  the  Swedish  BVD-eradication  programme. 
Preventive Veterinary Medicine 72 (1-2) 103-108.  
 
Paper I, III and V are reproduced by kind permission of Preventive Veterinary 
Medicine. 
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Abbreviations 
 
BHV-1  bovine herpesvirus type 1 
BTM  bulk tank milk 
BVDV  bovine viral diarrhoea  virus 
COD  corrected optical density 
cp  cytopathogenic 
ELISA  enzyme-linked immunosorbant assay 
FCS  foetal calf serum 
FMD  foot-and-mouth disease 
HR  hazard ratio 
IBR   infectious bovine rhinotracheitis   
IPB  infectious balanopostitis  
IHC  immunohistochemistry 
IPV  infectious pustular vulvovaginitis 
MD  mucosal disease 
ncp  non-cytopathogenic 
NCR  non-coding region 
nt  nucleotide 
OD  optical density 
OIE    Office International des Epizooties/  
    World Organisation for Animal Health 
ORF  open reading frame 
PI  persistently infected 
PP  percentage positive 
RT-PCR  reverse transcriptase-polymerase chain reaction 
SENASA  Servicio Nacional de Sanidad Agraria/ 
  National Agrarian Health Service 
VI  virus isolation 
VN  virus neutralization 
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Background 
Smallholder farming systems dominate livestock production in many developing 
countries, and are of crucial importance to both household and national economy, 
and thus also to rural development (McDermott, Randolph & Staal, 1999). These 
systems  have,  in  general,  a  lower  capacity  to  bear  economic  risk  compared  to 
large-scale  commercial  farms,  and  are  typically  much  closer  to  the  survival 
threshold  (McDermott,  Randolph  &  Staal,  1999).  This  is  why  smallholder 
households  are  particularly  affected  by  endemic  infectious  diseases  that 
continually  threaten  the  health  of  livestock,  and  cause  sub-optimal  production, 
reproduction and economic losses (Tisdell, Harrison & Ramsay, 1999).  
 
Smallholder farming systems dominate the dairy production in Peru, and ~95% 
of the farms have less than 20 animals (Bernet, Staal & Walker, 2001). A major 
obstacle  for  these  farmers,  and  for  the  national  dairy  production  in  general, 
consists of reproductive failures and the mean abortion rate in some dairy areas 
exceeds 15% (Olivera, 2001). Bovine viral diarrhoea virus (BVDV), endemic in 
most cattle-raising countries, is considered one of the major causative agents for 
these  failures  (Rivera,  2001).  The  present  project  deals  with  aspects  of  the 
epidemiology  of  BVDV  of  relevance  to  control,  with  particular  focus  on  the 
situation  in  Peruvian  smallholder  dairy  farms.  In  addition,  the  importance  of 
Neospora caninum and bovine herpesvirus type 1 (BHV-1) is addressed, because 
these  are  likely  differential  diagnoses  to  BVDV  in  herds  with  reproductive 
disorders. This project was supported by the Swedish International Development 
Cooperation Agency, Sida/SAREC. 
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Introduction 
Dairy production in Peru 
Peru’s  milk  consumption  is  low  by  South  American  standards  (Vera,  2000). 
However,  since  the  90s  there  has  been  a  consistent  effort  to  increase  the 
consumption, and the dairy industry has experienced an average annual increase of 
almost 5%. In 2003, there were 296 000 agricultural holdings, with a total of 635 
000 cows producing 1.2 million tons of milk (Portal Agrario). More than 50% of 
the national dairy production was produced in three main milk sheds: Arequipa in 
the  south,  Lima  in  the  centre,  and  Cajamarca  in  the  north.  Whereas  Holstein-
Friesian and  Brown Swiss  are the predominant dairy breeds among specialized 
dairy producers in the main milk sheds, the local criollo breed and cross breeds 
dominate among the smallest producers in the highlands. Approximately 95% of 
the specialized dairy producers have less than 20 cows, and an average annual 
milk yield of between 2000-4500 kg per cow, depending on production system and 
breed (Bernet, Staal & Walker, 2001).  
 
There  are  official  control  and  eradication  programmes  against  the  major 
livestock diseases: foot-and-mouth disease (FMD), bovine brucellosis and bovine 
tuberculosis,  run  by  the  National  Agrarian  Health  Service  (SENASA).  The 
prevalence of bovine brucellosis and bovine tuberculosis in the dairy population is 
low, estimated to 0.2% and 0.1%, respectively (SENASA, 2003). Since 1998, Peru 
has been conducting a plan to eradicate FMD throughout the national territory, and 
in  early  2005,  the  southern  region  (including  Arequipa)  was  approved  by  the 
World Organization for Animal Health (OIE) as free of FMD without vaccination 
(Fairfield, 2006).  
 
 
Bovine viral diarrhoea virus 
The virus 
BVDV  is  the  denomination  a  heterogeneous  group  of  viruses  in  the  family 
Flaviviridae, genus Pestivirus,  which primarily infects ruminants.  The virion is 
spherical, 40-60 nm in diameter, and consists of a lipid envelope surrounding a 
spherical  nucleocapsid.  The  genome  is  a  single-stranded  positive-sense  RNA 
molecule with a standard size of approximately 12.5 kb, and contains a single long 
open reading frame (ORF) flanked by 5’ and 3’ non-coding regions (NCR). The 
ORF is translated to a polyprotein of about 4000 amino acids, which is co- and 
post-translationally processed into the 11-12 mature proteins by viral and cellular 
proteases.  The  first  third  of  the  ORF  encodes  an  autoprotease  (N
pro)  and  four 
structural  proteins  (C,  E
rns,  E1,  E2),  whereas  the  remaining  part  of  the  ORF 
encodes for the non-structural proteins (p7, NS2-3, NS4A, NS4B, NS5A, NS5B) 
(reviewed in:  Ridpath, 2005a). 
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Biotypes 
BVDV can be divided into two biotypes: cytopathogenic (cp) BVDV and non-
cytopathogenic  (ncp)  BVDV  (Meyers  &  Thiel,  1996).  This  division  does  not 
correlate with virulence in vivo, but is based on the ability of the virus to induce 
cytopathic  effects  in  cell  cultures.  Whereas  cpBVDV  induces  apoptosis  of  the 
infected cell, ncp strains inhibit interferon synthesis and thus cell death (Schweizer 
& Peterhans, 1999, 2001; Perler et al., 2000). The molecular background of the 
different properties of the two biotypes concerns the processing and expression of 
the non-structural protein NS2-3 within the infected cells, and whereas ncp strains 
only  express  NS2-3,  cp  BVDV  also  expresses  the  non-structural  protein  NS3 
(Brownlie, 1990; Kummerer et al., 2000). This processing of NS2-3 in cp strains is 
associated with genetic alterations,  and  insertions, duplications or deletions are 
often found within the genome (Meyers & Thiel, 1996; Becher, Orlich & Thiel, 
1998, 2001).  In nature ncpBVDV predominate, and have the ability to establish 
lifelong persistent infections. Cytopathogenic BVDV strains, on the other hand, do 
not establish persistence, and are mainly isolated from cases of mucosal disease, a 
fatal form of BVDV that will be described later.  
 
Genotypes 
Traditionally, pestiviruses were classified based on host species of origin and three 
species were recognized: BVDV, Classical Swine Fever Virus, and Border Disease 
Virus. This classification, however, proved problematic when it was shown that 
some pestiviruses, particularly BVDV, could cross the species barrier (Paton et al., 
1995a). Today  classification of pestiviruses is based on  the genetic relatedness 
between isolates, including genetic similarity with the type virus of the species 
(Heinz  et  al.,  2000).  Furthermore,  because  pestiviruses  are  serologically  cross-
reactive, species demarcation considers antigenic relationships based on binding 
assays with monoclonal antibodies or cross-neutralisation assays with polyclonal 
antisera (Paton et al., 1995b; Hamers et al., 2001; Becher et al., 2003). Today the 
genus pestivirus consists of four accepted species, because it has been shown that 
isolates previously classified as BVDV are genetically and antigenically diverse, 
and can be divided into two different genotypes: BVDV-1 and BVDV-2 (Pellerin 
et  al.,  1994;  Ridpath,  Bolin  &  Dubovi,  1994).  Recently,  additional  tentative 
species  have  been  proposed,  isolated  from  wildlife  and  from  foetal  calf  serum 
(Becher, et al., 2003; Schirrmeier et al., 2004; Vilcek et al., 2005).  
 
The  two  genotypes  of  BVDV  can  be  further  subdivided,  and  at  least  11 
subtypes of BVDV-1 and 2 of BVDV-2 have been identified (Vilcek et al., 2001; 
Flores  et  al.,  2002;  Vilcek  et  al.,  2004).  This  heterogeneity  seen  among  field 
isolates is characteristic of RNA viruses, and is a result of the high mutation rate 
during viral replication due to the error prone viral RNA  polymerase (Bolin & 
Grooms, 2004). Despite this, BVDV strains isolated at different points in time, 
from different animals within a herd show high degree of homology, suggesting 
that BVDV is genetically stable after transmissions within the herd. This has led to 
the concept of herd-specific strains of BVDV, and is thought to be related to the 
role of immunotolerant, persistently infected (PI) animals within the herd (Paton, 
et al., 1995a; Hamers et al., 1998; Vilcek et al., 1999).    13 
 
Practical consequences of BVDV diversity 
Whereas BVDV-1 is the dominant genotype found worldwide, BVDV-2 appears 
to  prevail  mainly  in  the  United  States  and  Canada,  even  though  it  has  been 
reported  sporadically  also  in  Europe,  Asia  and  South  America  (Beer,  Wolf  & 
Kaaden, 2002; Flores, et al., 2002; Park et al., 2004; Cranwell, Jones & Wakeley, 
2005; Barros et al., 2006; Pizarro-Lucero et al., 2006). BVDV-2 was originally 
associated  with  outbreaks  of  severe  acute  BVDV  or  haemorrhagic  syndrome 
(Corapi et al., 1990); today however, it is well accepted that most BVDV strains 
are  low  virulent,  and  exhibit  the  same  range  of  pathogenicity  regardless  of 
genotype or subgenotype  (Ridpath, 2005b). The practical implication of BVDV 
diversity is thus not primarily related to differences in clinical consequences, but 
rather  to  biologically  significant  differences  in  antigenic  determinants  between 
genotypes  and  subtypes  (Fulton  et  al.,  2003a,b;  Ridpath,  2005b),  and  several 
studies indicate that  these differences may contribute  to  BVDV vaccine failure 
(Zimmer et al., 2002; Fulton et al., 2005). Genetic and antigenic diversity should 
also be considered when designing diagnostic assays because it is essential that 
assays used for BVDV control purposes are sufficiently broadly reactive to detect 
all circulating strains. 
 
 
Clinical manifestations 
Contrary to what might be expected from its name, BVDV can be associated with 
pathology  in  most  organ  systems,  including  the  respiratory,  gastroenteric  and 
reproductive systems. The outcome of a postnatal infection depends to a certain 
extent on viral factors, i.e. genetic and antigenic properties of the infecting strain 
(Ridpath et al., 2000). More important for the outcome, however, are two main 
factors  associated  with  the  infected  animal:  whether  it  is  pregnant  or  not,  and 
whether  or  not  it  has  been  exposed  previously  (reviewed  in:  Baker,  1995; 
Evermann  &  Barrington,  2005).  Immunocompetent  animals  that  have  been 
exposed previously have long-lasting immunity (Fredriksen et al., 1999). 
 
Infection in seronegative non-pregnant  animals may result in severe disease, 
depending  on  the  infecting  strain  (Corapi,  et  al.,  1990),  but  is  in  most  cases 
subclinical.  Typical  clinical  symptoms  are  fever,  transient  leucopoenia, 
inappetence  and  mucosal  erosions,  and  in  calves,  also  respiratory  and 
gastrointestinal  signs.  These  signs  can  be  a  direct  consequence  of  the  BVDV 
infection, but also a result of secondary or concurrent infections, because BVDV is 
known  to  induce  immunosuppression  and  increase  susceptibility  to  other 
pathogens (de Verdier Klingenberg, Vagsholm & Alenius, 1999).  
 
The main economic impact of BVDV infections, however, is probably caused 
by  infections  in  the  seronegative  pregnant  animal  that  result  in  transplacental 
transmission  and  foetal  infection  (reviewed  in:  Grooms,  2004).  The  specific 
outcome of the foetal infection depends primarily on the stage of gestation, and 
thus on the gestational age of the early conceptus or foetus, and a wide range of 
reproductive  disorders  can  be  seen  in  infected  herds.  These  include  embryonic   14 
deaths, abortions, malformations, birth of stillborn or weak calves, or birth of PI 
calves. Abortions are most common during the first trimester but may occur at any 
time during pregnancy. Foetuses infected from around 30 days in gestation, and 
until the foetus becomes immunocompetent at around 120 days in gestation may 
be born PI with BVDV. PI calves are immunotolerant to the infecting strain, and 
are in general seronegative. If exposed to a heterologous strain, however, they may 
develop an antibody response (Bruschke et al., 1998;  Fulton, et al., 2003b). PI 
calves  shed  large  quantities  of  virus  throughout  their  lives  and  are  the  key 
transmitters of the infection. They are often born weak and undersized, but many 
appear normal at birth. Due to an impaired immune system they are particularly 
susceptible  to  other  infections,  which  partly  explains  the  high  mortality  during 
young  age,  compared  to  non-infected  calves  (Houe,  1999).  Some  PI  animals 
remain  clinically  unaffected  and  may  breed  satisfactorily  (McClurkin,  Coria  & 
Cutlip, 1979). They will then transmit the infection to the foetus, and the offspring 
will always be PI.  
 
Foetuses infected during later stages of gestation are in general able to develop 
an effective immune response and clear the virus. Despite this, many congenitally 
infected non-PI calves are weak at birth, and may be at more risk of experiencing 
serious postnatal health effects (Munoz-Zanzi et al., 2003).  
 
Mucosal disease 
Mucosal disease (MD) is a fatal form of BVDV that develops when a PI animal is 
superinfected with a cp strain of the virus (Brownlie, 1990). The source of the 
superinfecting cp strain is either endogenous, i.e. a result of a mutation in the non-
structural part of the genome of the resident ncp strain within the PI animal, or 
exogenous,  e.g.  from  a  live  BVDV  vaccine.  MD  is  characterized  by  fever, 
anorexia, and massive mucosal erosions throughout the gastrointestinal tract, with 
profuse diarrhoea and death within a few days in the acute form of the disease. In 
the more protracted form, so-called late-onset MD, the animal may survive several 
months before the onset of disease. 
 
 
Epidemiology 
Prevalence 
Infections with BVDV are widespread in most cattle-raising countries, with herd-
level seroprevalences typically ranging between 70-100% in endemic areas, with 
60-75% of the cattle being antibody carriers, and with an estimated prevalence of 
PI  animals  of  1-2%  (Houe,  2005).  Given  the  assumption  that  presence  of 
antibodies reflects exposure to the pathogen, it can be concluded that BVDV is 
present  worldwide.  However,  considering  the  persistence  of  BVDV  specific 
antibodies (Fredriksen, et al., 1999), serosurveys may give positive results years 
after last exposure to the virus, and the prevalence of herds with indications of 
current  infection  shows  considerable  variation,  both  on  a  regional  and  on  a 
national level (Paton et al., 1998; Graham et al., 2001; Mainar-Jaime et al., 2001; 
Viltrop  et  al.,  2002;  Kampa  et  al.,  2004).  In  non-vaccinated  populations  with 
endemic BVDV, the within-herd seroprevalence is mainly dependent on whether   15 
PI animals are present in the herd or not. In general, the seroprevalence is high in 
herds with PI animals as a result of the efficient spread of virus from the PIs to the 
surrounding  group  (Lindberg  &  Alenius,  1999).  The  prevalence  and  age 
distribution of seropositive animals in herds without PI animals, on the other hand, 
reflects the time that has passed since the elimination of the last PI (Houe, 1992), 
and theoretically, all individuals born after the elimination of the last PI animal are 
seronegative. This means that the within-herd seroprevalence will decrease at a 
pace  dependent  on  the  replacement  rate,  as  long  as  the  replacing  animals  are 
seronegative and non-PI.  
 
Transmission 
PI animals are the main source of infection within the infected herd, because they 
shed virus in very high concentrations in all bodily fluids throughout their life. 
Transiently infected animals may be a source of horizontal infection, and a few 
reports  suggest  that  BVDV  may  persist  in  a  herd  in  absence  of  PI  animals 
(Moerman et al., 1993; Moen, Sol & Sampimon, 2005). However, because they 
shed comparably lower amounts of virus and only for a few days during acute 
infection  (Brownlie  et  al.,  1987),  their  importance  for  viral  transmission  and 
persistence  of  the  infection  within  the  herd  is  limited  (Niskanen,  Lindberg  & 
Traven, 2002; Lindberg & Houe, 2005).  
 
The conventional way of spread of BVDV between herds is through trade or 
contact  with  infected  animals  (particularly  PIs,  but  also  transiently  infected 
animals), or through trade with dams carrying PI foetuses (PI carriers). In addition, 
infection can be introduced to a susceptible herd by indirect means, through the 
use of contaminated biological by-products such as live vaccines (Falcone, Tollis 
&  Conti,  1999;  Barkema  et  al.,  2001),  or  through  contaminated  or  infected 
embryos  or  semen    (Givens  &  Waldrop,  2004).  Wildlife  reservoirs  have  been 
suggested  as  a  possible  source  of  transmission  of  BVDV  (Anderson  &  Rowe, 
1998; Pizarro-Lucero et al., 2005), but even though persistent infections in non-
bovine  hosts  have  been  confirmed  (Vilcek  et  al.,  2000;  Pizarro-Lucero,  et  al., 
2005), the importance of this source is unclear (Lindberg & Houe, 2005).  
 
Impact 
Production losses and damage caused by BVDV can be considerable due to the 
broad effect on reproduction and general health in infected herds. Total costs due 
to  the  infection  may  include  losses  due  to  reduced  milk  production,  reduced 
reproductive performance, growth retardation, and increased mortality and culling 
rate, as well as  extra expenses for treatments of diseased animals.  To quantify 
long-term losses associated with BVDV is difficult due to the insidious nature of 
the disease. Most estimates have been based on case studies from individual herd 
outbreaks, and these estimates are very variable and range between $25-410/cow-
year (Houe, 2003).  Losses in  any single  case depend on factors  as  initial herd 
immunity, number of cows in early pregnancy, and virulence of infecting strain, 
and new infections in naïve herds can be associated with very high, but transient 
losses. In a recent study, long-term losses due to ongoing BVDV infection within a 
typical French dairy were estimated at between €75-133/cow-year, depending on   16 
the  severity  of  the  infection.  The  total  costs  due  to  BVDV  infection  were 
comparable with costs due to mastitis (Fourichon et al., 2005). At the national 
level, most estimates of the losses due to BVDV lie in the range of $10-40 million 
per million calvings (reviewed in: Houe, 2003).  
 
 
Control 
For  long,  attempts  to  control  BVDV  infections  were  limited  to  prophylactic 
vaccination practices, implemented primarily to reduce or prevent clinical disease 
on  a  herd  basis.  Today,  however,  it  is  well  established  that  the  benefit  of 
preventing  clinical  disease  in  transiently  infected  animals  is  negligible  when 
considering the overall prevention and control of the disease (Brock, 2004). It is 
also well established that the PI animal is the key to the evolutionary success of 
BVDV,  and  that  prevention  of  foetal  infection  is  the  key  to  BVDV  control 
(Lindberg & Alenius, 1999). Consequently, modern vaccination programmes are 
designed not only to prevent clinical disease, but also to protect against viremia 
and to prevent foetal infection (reviewed in: Kelling, 2004; Fulton, 2005). Several 
challenge studies indicate that inactivated as well as live vaccines may prevent 
foetal  infection  under  controlled  experimental  conditions  (Cortese  et  al.,  1998; 
Frey et al., 2002; Patel et al., 2002). However, the efficacy of these vaccines to 
protect foetuses against infection under field conditions have been questioned (van 
Oirschot, Bruschke & van Rijn, 1999; O'Rourke, 2002; Graham et al., 2003), and 
field observations, where PI calves have been born in vaccinated herds, support 
this concern (Van Campen et al., 2000; Gaede et al., 2004; Graham et al., 2004). 
The antigenic diversity among BVDV field strains may, as previously mentioned, 
partly  explain  theses  vaccine  failures.  However,  difficulties  associated  with 
reaching complete foetal protection under field conditions are not only related to 
vaccine and viral properties, but also to human factors, as inconsistent use of the 
vaccines,  combined  with  the  risk  of  conveying  a  false  sense  of  security,  with 
subsequent biosecurity
1 breaches.  Moreover, because 100% efficacy and coverage 
is  needed  to  prevent  the  infection  from  being  established,  if  it  is  introduced, 
vaccination has, despite the widespread use, failed to reduce the incidence and 
prevalence of BVDV (Lindberg & Houe, 2005).  
 
Another strategy to control BVDV has evolved during the last decades within 
eradication programmes in Europe, and particularly in the Scandinavian countries. 
This has been based on an initial determination of herd BVDV status, followed by 
implementation of systematic zoo-sanitary measures at a regional or national scale 
(without the use of vaccines) to prevent introduction of BVDV in non-infected 
herds,  and  to  reduce  the  prevalence  of  infected  herds  by  identification  and 
elimination of PI animals (Lindberg & Alenius, 1999; Greiser-Wilke, Grummer & 
Moennig, 2003; Sandvik, 2004). These programmes have been very successful, 
and all of the Scandinavian countries are currently either free, or almost free from 
                                                             
1 Biosecurity in this context means reduction of risk factors for introduction and spread of 
the infection.    17 
BVDV (Nyberg, Østerås & Plym-Forshell, 2004; Hult & Lindberg, 2005; Rikula 
et al., 2005).  
 
Today, after the success of the control programmes in Scandinavia, it is well 
established that BVDV control must comprise the necessary elements: biosecurity, 
virus elimination and monitoring. The role of vaccination, on the other hand, is 
more controversial. According to a general model proposed by Lindberg and Houe 
(2005), vaccination of non-PI animals without natural immunity, could, in addition 
to the three necessary elements, constitute an optional element in areas where the 
risk of re-introduction into free herds is perceived as very high, and such a model 
is currently underway in Germany (Moennig et al., 2005). 
 
Self-clearance 
Reduction of the prevalence of infected herds can, as previously mentioned, be 
achieved through systematic identification and elimination of PI animals. Under 
some circumstances, however, infection may be eliminated from an infected herd 
without intervention, i.e. through self-clearance. This is an important phenomenon 
that works in favour of control, and that occurs when PI animals do not succeed in 
establishing additional persistent infections before they are removed from the herd 
due to death, trade or culling (Lindberg & Houe, 2005).  
 
 
Diagnostics 
In general, diagnostic assays for detection of BVDV infections can be divided into 
serological methods, i.e. methods aimed at detection of virus-specific antibodies as 
an  indication  of  exposure  to  the  pathogen,  and  methods  aimed  at  detection  of 
infectious virus or viral components (antigen or nucleic acids), as an indication of 
current infection (reviewed in: Sandvik, 2005).   
 
Serological methods 
In the context of BVDV control, the main objectives of serological methods are to 
differentiate  between  exposed  and  non-exposed  herds,  to  monitor  progress  and 
drawbacks  within  an  ongoing  control  programme,  and  to  investigate  immune 
status  in  individual  animals  in  infected  herds,  to  identify  possible  PI  animals 
(Lindberg & Alenius, 1999). A PI animal is, as previously mentioned, generally 
seronegative, unless it has persisting maternal antibodies, or has been exposed to 
and infected with a heterologous strain. Serological methods can also be used to 
diagnose acute infection by detection of seroconversion in paired samples.  
 
Virus neutralization 
Virus  neutralization  (VN)  is  the  reference  test  for  antibody  detection.  VN  is 
sensitive and specific, but cell culture dependent and labour demanding and will 
typically take 5-6 days to perform. Thus, it is mostly used as a reference test for 
back-up and calibration purposes (Sandvik, 2005).   
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Antibody ELISA 
For  testing  of  large  series  of  samples,  enzyme-linked  immunosorbent  assays 
(ELISAs) have many advantages over VN. They are rapid, relatively inexpensive 
both  to  establish  and  run,  and  are  suitable  for  automation.  Two  principally 
different  ELISA formats are common in use for antibody detection: indirect or 
blocking  (competitive)  assays.  In  the  indirect  format,  specific  antibodies  are 
trapped by immobilized viral antigen, and subsequently detected using enzyme-
conjugated  species-specific  antiglobulins.  A  positive  reaction  is  recognized  by 
colour development in the substrate solution, which is read optically and reported 
as optical density (OD) values. In blocking ELISAs, virus-specific antibodies in 
the sample block the binding of conjugated virus-specific antibodies to fixed viral 
antigen. Thus, a positive sample causes a reduction of the OD, which is expressed 
as a percent inhibition, relative to the OD of a negative reference serum. Antibody 
ELISAs are widely used within BVDV control programmes, either as herd-level 
tests aimed at detecting antibodies in pooled samples of milk or serum, or at the 
individual level. 
 
Detection of virus 
Two  main  objectives  for  the  application  of  virus  detection  assays  can  be 
distinguished: firstly, to identify PI animals within infected herds, for subsequent 
removal, and secondly to certify the non-infectious status of individual animals, 
semen or embryos, to prevent introduction of infection into non-infected herds or 
populations. Commonly used methods include virus isolation, different immune 
based antigen detection assays, such as ELISA or immunohistochemistry (IHC), 
and RT-PCR. 
 
Virus isolation 
Virus isolation (VI) in bovine cell cultures, followed by identification of the viral 
isolate by immunoperoxidase or  immunofluorescence staining is considered  the 
standard  reference  test  for  detection  of  infectious  virus.  Although  VI  demands 
time,  resource  and  skill,  it  is  a  reliable  and  widely  used  method.  Presence  of 
antibodies, or cell toxic substances, or both in the sample, however, can yield a 
false negative result. Furthermore, because BVDV is a common contaminant of 
biological  by-products  of  bovine  origin  such  as  foetal  calf  serum  (FCS)  and, 
consequently,  bovine  cell  cultures  grown  in  FCS-supplemented  media,  the  cell 
culture  system  must  be  monitored  to  ensure  freedom  from  contamination  with 
virus or antibodies (Bolin, Matthews & Ridpath, 1991). 
 
Detection of antigen 
Assays for detection of viral antigen rely on existing BVDV-encoded antigens in 
the sample material, i.e. there is no amplification of the target, as is the case for VI 
and RNA detection protocols. This minimises the risk of cross contamination of 
samples, and also favours detection of PI over acutely infected animals (Sandvik, 
2005). 
 
Several formats of ELISAs are commercially available for detection of viral 
antigens.  The  basic  principle  consists  of  the  use  of  virus-specific  monoclonal   19 
antibodies  to  capture  viral  antigens,  followed  by  detection  of  antigen-antibody 
complex with enzyme-conjugated antibodies. Antigen ELISAs are widely used for 
identification of PI animals, and can be used for detection of virus in serum, buffy 
coat cells or skin biopsies (e.g. ear notch samples). Like VI, antigen ELISAs may 
yield false negative results if antibodies are present in the sample. This should be 
considered  when  testing  young  animals  that  might  have  persisting  maternal 
antibodies (Zimmer et al., 2004).  
 
Immunohistochemical  detection  of  antigen  in  skin  biopsies,  particularly  ear 
notch  samples,  is  another  method  that  is  used  for  identification  of  PI  animals 
(Brodersen,  2004).    This  method  is  considered  suitable  for  mass  screening  of 
young calves both because ear notch samples can be obtained with relative ease 
and IHC can be applied for detection of viral antigen in young PI calves without 
risk of interference with persistent maternal antibodies.  
 
RT-PCR 
 Reverse  transcription-polymerase  chain  reaction  (RT-PCR)  is  a  rapid  and 
sensitive  method  for  detection  of  viral  RNA  that  has  the  advantage  of  being 
insensitive  to  toxic  substances  in  the  specimen.  A  general  RT-PCR  protocol 
includes  four  different  steps:  extraction  of  RNA,  reverse  transcription  to 
complementary DNA, primer-directed  amplification,  and  detection of  amplified 
products. In the classical protocols, these steps are carried out separately, which is 
time-consuming, and which increases the risk of cross-contamination of samples. 
More recent real-time RT-PCR systems combine the last three steps in a single 
tube, and by eliminating the need for gel electrophoresis, the risk of carry-over 
contamination with previously amplified DNA yielding false positive results  is 
greatly reduced (McGoldrick et al., 1999). By use of separate sets of primers and 
probes,  BVDV-1  and  -2  can  also  be  discriminated  between  in  the  same  assay 
(Letellier  &  Kerkhofs,  2003).  Furthermore,  by  direct  sequencing  of  the  PCR 
products, phylogeny studies can be performed for rapid and exact identification of 
virus variants. 
 
Genotyping 
The  genetic  typing  of  BVDV  has  most  frequently  been  based  on  sequence 
comparison of partial sequences of the 5’ NCR, Npro or E2 regions (Vilcek, et al., 
2001; Becher, et al., 2003; Nagai et al., 2004; Toplak et al., 2004). Analysis of the 
5’ NCR, a highly conserved region of the genome, has shown to be a reliable and 
reproducible  method  for  genetic  characterization  of  BVDV  isolates  (Ridpath, 
2005b) even though the genetic resolution obtained is not as high as that obtained 
with more variable regions as Npro or E2. Furthermore, it is the target region for 
most PCR-based diagnostics, and as such a suitable target for direct sequencing 
from the PCR product.  
 
Neospora caninum 
Neospora  caninum  is  an  intracellular  protozoan  parasite,  closely  related  to 
Toxoplasma gondii, which is increasingly recognized as a major cause of bovine 
abortions (reviewed in: Anderson, Andrianarivo & Conrad, 2000; Dubey, 2003). 
Abortions associated with the infection occur from month 3 of gestation to term   20 
with a peak in incidence during month 4-6. The main transmission route in cattle is 
vertical, i.e. by transmission of  the parasite from  the  cow to her foetus during 
gestation. In addition, horizontal transmission may occur, and refers to cattle being 
infected  postnatally  by  ingestion  of  oocysts  excreted  from  a  definitive  host 
(McAllister et al., 2000; Dijkstra et al., 2002). Currently, dogs and coyotes are the 
only species verified as being definitive hosts of the parasite, and presence of dogs 
at  the  farm  has  been  identified  as  an  important  risk  factor  associated  with 
Neospora caninum related abortions as well as high prevalence (Bartels, Wouda & 
Schukken,  1999;  Mainar-Jaime  et  al.,  1999).  Neospora  caninum  infected 
individuals remain carriers of the infection for life, and may pass the infection to 
their offspring (Björkman et al., 1996). However, not all calves born from infected 
cows are congenitally infected, and what decides the outcome of pregnancy in an 
infected cow is still unknown (Innes et al., 2002). 
 
For laboratory diagnosis of Neospora caninum in the live animal, serological 
assays  are  generally  applied,  because  presence  of  Neospora  caninum  specific 
antibodies,  in  general,  indicates  that  the  animal  is  infected  with  the  parasite. 
Several assays have been developed for detection of antibodies in serum and milk, 
and indirect-fluorescent antibody tests (IFAT) and ELISAs are among the most 
commonly used (Björkman & Uggla, 1999).  
 
 
BHV-1  
Bovine herpesvirus type 1 belongs to the family Alphaherpesvirinae, and is an 
economically important pathogen of cattle, with worldwide distribution (reviewed 
in: Kahrs, 1977; Straub, 2001). It is the causative agent of respiratory and genital 
tract  infections  such  as  infectious  bovine  rhinotracheitis  (IBR)  and  infectious 
pustular vulvovaginitis/infectious balanopostitis (IPV/IBP), and abortion. As with 
other  herpesvirus,  BHV-1  can  establish  latency,  during  which  the  agent  is 
harboured in the sensory ganglia as viral DNA (Ackermann, Peterhans & Wyler, 
1982). Reactivation from the latent state and re-excretion of virus can occur (after 
stimuli, such as stress or corticosteroid treatment) with the risk of transmission to 
susceptible animals (Pastoret & Thiry, 1985; Thiry et al., 1987). Upon introduction 
of the virus into a susceptible herd,  the  infection typically spreads rapidly  and 
completely, resulting in clinical or subclinical disease and seroconversion (Hage et 
al., 1996). 
 
The  conventional  way  of  controlling  BHV-1  in  most  parts  of  the  world  is 
through vaccination. In a few countries within Europe (including Switzerland and 
the Scandinavian countries), however, BHV-1 has been eradicated through culling 
of seropositive animals. Most BHV-1 vaccines reduce the severity of the disease, 
and also virus replication and transmission, but are not able to prevent infection 
and the establishment of latency (Ackermann & Engels, 2006). 
 
As  for  BVDV,  diagnostic  assays  for  detection  of  BHV-1  infections  can  be 
divided into serological methods, and methods aimed at detection of virus. Various 
antibody ELISAs are commonly used, and seropositive cattle are considered to be 
latently infected. Modern ELISAs, developed together with gene-deleted marker   21 
vaccines, can be used to differentiate vaccinated animals from naturally infected 
animals. This is considered critical for trade within Europe (van Drunen Littel-van 
den Hurk, 2006). For virus detection, VI and PCR are commonly used (Straub, 
2001).   22 
Aims 
The  overall  aim  of  this  project  was  to  address  questions  regarding  the 
epidemiology  of  BVDV  of  relevance  to  control,  with  particular  focus  on  the 
situation in Peruvian smallholder dairy farms. In addition, the ambition was  to 
transfer  knowledge  and  experience  gained  within  the  Swedish  BVDV  control 
programme to relevant institutions in Peru. 
 
More specifically, the following aims were: 
 
• To introduce appropriate and rapid methods for herd-level testing, and to use 
them to estimate the current status of BVDV, Neospora caninum, and BHV-1 in 
smallholder dairy herds in Peru (I-II). 
• To  estimate  the  probability  of  self-clearance  of  BVDV  infections,  and  to 
investigate possible herd and management associated with it (II). 
• To  investigate  the  association  between  BVDV  and  Neospora  caninum,  and 
endemic abortions in a dairy herd with reproductive disorders (III). 
• To describe the genetic diversity of BVDV strains circulating in Peru (IV). 
• To  characterize  BVDV  strains  that  circulate  in  Sweden,  and  to  investigate 
whether  a  molecular  epidemiological  approach  may  serve  to  trace  routes  of 
transmission (V). 
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Methodological considerations 
Detailed descriptions of materials and methods applied are given in each paper. 
 
Study populations 
Our first study (Paper I) was carried out in the Mantaro Valley; an agricultural 
region in the central highlands where mixed small-scale animal and crop farming 
is the dominant system. Traditionally, this was an important dairy region, but the 
political circumstances in the country during the 1980s and early 1990s severely 
affected the region, and hampered the expansion of the dairy sector (Fernandez-
Baca & Bojorquez, 1994). Difficult access, due to the poor conditions of the road 
system that links the highlands to the coast, also contributed to the regression and 
isolation of the sector. Today, however, with political stability in the country and 
infrastructural  investments  being  made,  the  dairy  sector  in  the  region  has  the 
potential to expand. The estimated annual milk production in 2003 was 19000 tons 
(Portal Agrario). At the time this study was performed, none of the major dairy 
companies were present in  the region, and  there was  a  lack of information on 
livestock demography. The selection of the 60 herds included in the study was 
therefore based on convenience. 
 
The following studies (Papers II-III) were carried out in the region of Arequipa 
in southern Peru. This is the most important milk shed in country, with an annual 
production in 2003 of 270 000 tons, i.e. 22% of the national production (Portal 
Agrario). Unlike Mantaro Valley, the dairy sector in Arequipa has been expanding, 
and during the last decades thousands of dairy cattle have been imported to the 
region, from North America, Europe, and other countries within South America. 
Furthermore,  due  to  the  presence  of  major  dairy  companies  in  the  region,  the 
infrastructure is good. Today, the number of dairy producers in the region is 7000-
8000, with 50000- 60000 cows in production. Cattle density is high, reaching 150- 
200 animals/km
2. 
 
 
Study design 
Paper I-II 
In  Paper  I  we  selected  60  herds  in  the  Mantaro  Valley,  and  visited  them  in 
October- November 1998 for BTM sampling. In Paper II we selected 221 herds for 
BTM sampling, and a subset of 55 herds for data collection and individual blood 
sampling from a number of young animals (spot tests). BTM was collected at the 
milk  collection  plant  in  Majes,  Arequipa,  on  two  occasions,  in  August  2003 
(n=192) and in February 2004 (n=195), and the 55 herds were visited for spot 
testing and data collection in December 2003. 
 
We used BTM tests and spot tests to determine the BVDV status of the herds, 
i.e. to predict absence or presence of current infection. In addition, BTM samples 
were used for determination of herd-level status of Neospora caninum (Paper II) 
and BHV-1 (Paper I). The prevalence of herds with evidence of BVDV exposure,   24 
but without indication of current infection, was then used as an indirect estimate of 
the probability of self-clearance (Paper II). Basic herd data and information on 
farm  biosecurity  were  gathered  through  a  short  questionnaire,  and  a  logistic 
regression model was used to investigate possible associations between herd and 
management factors, and the probability of self-clearance.  However, as many of 
the farmers did not keep written records only very basic and robust information 
could be included in the analysis.   
 
Paper III 
In Paper III we selected a herd with a history of endemic abortions, to investigate 
the association between abortions, and BVDV or Neospora caninum infections or 
both. All animals >6 months were tested for antibodies to BVDV and Neospora 
caninum at the start of the study. Animals that were seronegative to BVDV were 
then tested for antigen, and those identified as PI animals were eliminated. The 
group of animals tested at the initial screening were followed for two years, and 
calvings,  abortions  and  cullings  were  recorded.  During  this  time,  changes  in 
BVDV status were monitored by consecutive samplings of young stock, and PI 
animals were identified and eliminated. The herd was considered free from BVDV 
infection one year after the start of the study. In the analysis, the results from the 
initial screening were used to classify animals as Neospora caninum infected, or 
not. Regarding BVDV, on the other hand, seropositivity in individual animals is 
not an indication of ongoing infection, but of long-lasting immunity after previous 
exposure  to  the  agent  (Fredriksen,  et  al.,  1999).  Therefore  BVDV  status  was 
assessed at the herd level and included as a seasonal effect.  
 
Paper IV 
BVDV  isolates  from  animals  identified  as  PI  in  Papers  I-III,  were  genetically 
characterized in paper IV, and used to describe the genetic diversity of BVDV in 
Peru. In addition, we characterized a number of strains from major dairy regions in 
Chile. 
 
Paper V 
In  this  study  a  molecular-epidemiological  approach  was  applied  within  the 
Swedish BVDV control programme. The control programme has been successfully 
running since 1993 and is in its final phase, and by August 2005, 97.8% of all 
herds  were  officially  free  from  BVDV.  Nevertheless,  new  infections  are  being 
detected despite  the strict rules of the programme. Since 2002 there have been 
established routines to trace sources of new transmission and thereby identify risky 
behaviour. Still, in about 40% of the cases where new infections are detected in 
previously  free  herds,  the  route  of  transmission  remains  unidentified.  The  first 
results from this study were published in Paper V, but the project is continuing 
with the purpose to characterize BVDV strains that circulate in Sweden and to 
build up a bank of BVDV isolates from all remaining herds detected as infected 
within the programme. The purpose is also to apply the molecular-epidemiological 
approach to trace routes of infection and to survey the national BVDV situation.  
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Comments on herd-level tests 
The cost-efficiency of BVDV control, as implemented in Scandinavia has been 
dependent on the use of rapid and cheap herd-level tests as BTM tests or spot tests 
for screening and monitoring (Lindberg & Alenius, 1999). BTM  is particularly 
convenient because it is easy to collect and handle, and covers the entire lactating 
population  within  one  sample,  which  facilitates  screening  of  large  populations. 
However, results from a single BTM test should be interpreted cautiously since it 
excludes non-lactating individuals. Thus, a herd may be falsely considered non-
infected (or infected) if a large proportion of the seropositive  (or the seronegative) 
cows  are  dry  or  low  producing  at  the  day  of  the  sampling.  This  problem  is 
probably larger in small herds, because milk from an individual animal will then 
represent a larger proportion of the BTM. By using repeated sampling, however, 
one  can  reduce  the  probability  of  such  misclassification  and  increase  the 
usefulness of the test.  
 
Herds  with  current  infection  will  generally  have  high  within-herd 
seroprevalence of BVDV, and, consequently, high levels of BVDV antibodies in 
BTM  (Niskanen,  1993).  On  the  other  hand,  herds  with  previous  exposure  to 
BVDV, but without current infection, may also have high levels of antibodies in 
BTM due to high and long-lasting antibody titres in previously infected animals. 
Generally, the prevalence of seropositive animals, and consequently the antibody 
levels in BTM, will decrease at a pace dependent on the replacement rate, as long 
as  the  replacing  animals  are  seronegative  and  non-PI.  In  smallholder  dairy 
systems, replacement rate is typically slow because cows are kept longer than in 
larger  commercial  dairy  systems,  and  this  should  be  kept  in  mind  when 
interpreting  the  results.  In  regions  where  the  use  of  vaccines  (particularly  live 
vaccines) is widespread, the vaccination status of the herd should be considered, 
because the potential presence of vaccine-induced antibodies in vaccinated herds 
creates difficulties in the interpretation of the results. 
 
A spot test is a herd-level test based on individual samples of serum or milk 
from a small number of animals of a certain age group, which can be used to 
predict  presence  or  absence  of  current  BVDV  infection  in  herds  with  high 
antibody levels in BTM due to previous exposure (or vaccination). This principle, 
used  within  BVDV  control  programmes  in  Scandinavia,  is  based  on  the  high 
probability of seropositivity in groups of animals where PI animals are present 
because of the efficient spread of virus from PI animals to the surrounding group 
(Lindberg & Alenius, 1999). A negative spot test in a (non-vaccinated) herd with a 
positive BTM test indicates that the herd has been exposed to BVDV, but that the 
infection has been eliminated. Given that the infection has been eliminated without 
intervention,  a  negative  spot  test  can  be  interpreted  as  an  indication  of  self-
clearance (Paper II). As with other herd-level tests, results from single spot tests 
should  be  interpreted  cautiously  and  should  not  be  used  to  rule  out  infection, 
because herds where PI animals have recently been introduced might be missed. 
To be reliable and useful for monitoring within a control programme spot tests 
must therefore be repeated at regular intervals.  
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Survival analysis 
In  Paper  III,  Cox  proportional-hazards  models  were  used  to  investigate  the 
association between Neospora caninum and BVDV infections, and the endemic 
abortions.  These are semi-parametric survival models that ignore the distribution 
of the survival-time (i.e. time-to-abortion in this case) and that assume that the 
hazard ratio, i.e. the effect of a unit change in a predictor on the frequency of the 
outcome, is constant. By using survival models in the analysis, we could utilize 
information from all observations, even from those lost to follow-up (e.g. cows 
that were sold or culled) while at risk of abortion. This way we could also model 
the herd-level effect of BVDV as time-dependent, because the BVDV status of the 
herd changed during the study. The preliminary data suggested that the assumption 
of  proportional  hazards  was  violated  and  that  the  effect  Neospora  caninum 
infections on the abortions was dependent on when the abortions occurred. This 
observation was supported by previously published results (Lopez-Gatius, Pabon 
& Almeria, 2004). Therefore, two outcomes for the models were defined: early 
abortions (between day 42 and day 100 in gestation), and late abortions (after day 
100). In the models, we considered the possible confounding by parity and animal 
origin. Furthermore, because data from repeated pregnancies were included, we 
also considered possible lack of independence between observations, and included 
frailty  effects.  The  coefficients  for  the  frailty  effects  were  not  significantly 
different from zero, however, and were excluded from the final models. 
 
 
PCR and genotyping 
In Paper IV and V, standard protocols were used to amplify and characterize a 
segment  of  the  5´NCR  of  included  BVDV  strains.  This  included  routine 
precautions  and  safety  measures  to  avoid  cross  contamination  of  the  samples 
(Belak & Ballagi-Pordany, 1993). For the RT-PCR we used a fully automated one-
step  protocol,  which  further  reduced  the  handling  of  the  samples  and, 
consequently, the risk of  contamination.  The target region was then sequenced 
directly  from  the  PCR  product.  For  the  phylogenetic  analysis  we  used  a  237 
nucleotide fragment of the 5´NCR, corresponding to position 135-371 of BVDV 
SD-1  (Deng  &  Brock,  1992).  Reference  strains  and  previously  described  field 
isolates  representing  different  subtypes  of  BVDV-1  were  obtained  from  the 
GenBank and included for comparison. Phylogenetic trees were constructed using 
neighbour-joining, and bootstrap resampling was used to evaluate the robustness 
of the method.    27 
Results and discussion 
A detailed description and discussion of the results is given in each paper.  
 
Prevalence of BVDV infections and self-clearance (Papers I and II) 
BTM 
The results from the BTM testing clearly demonstrated that most of the herds in 
Mantaro Valley (92%) as well as Arequipa (100%) had been exposed to BVDV. 
However, whereas >95% of the herds in Arequipa had high levels of antibodies in 
BTM, suggesting current or recent infection,  most of the  herds in the  Mantaro 
Valley (73%) had low or moderate levels (Fig.1). This discrepancy reflects the 
differences  of  the  study  populations.  The  dairy  sector  in  Arequipa  is  strongly 
influenced by the presence of the major dairy companies and the easy access to the 
national dairy market in Lima (Bernet, Pradel & Walker, 2001). The expansion of 
the sector has led to high cattle density, and to introduction of large numbers of 
livestock, in most cases with insufficient, or lacking health documentation. Given 
an approximate prevalence of PI animals of 2% (including PI carriers), the risk (P) 
of introducing BVDV when buying 100 cattle with unknown BVDV status is P=1-
0.98
100  = 87% (Houe, 1999). In the Mantaro Valley, on the other hand, the relative 
isolation has prevented massive introduction of livestock, and this has resulted in a 
reduced risk of introducing BVDV.  
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Figure 1. Distribution of BVDV corrected optical density values (COD) in bulk tank milk  
(BTM) as measured in an indirect ELISA (SVANOVA, Biotech, Uppsala, Sweden). BTM 
samples were collected in dairy herds in the Mantaro Valley (n=60) and Arequipa (n=195), 
Peru, in 1998 and 2004, respectively. 
 
Spot tests 
From the 55 herds we collected serum samples from 267 animals, i.e. 4-5 from 
each herd. Of these, 152 animals tested negative, and 115 positive. The spot tests 
from  35  herds  (64%)  had  ≤2  positive  samples,  and  were  considered  negative.   28 
Consequently, despite the high infection pressure and the high cattle density in 
Arequipa, almost two thirds of the herds had spot test results suggesting absence of 
current infection. Given that these herds previously had been infected with BVDV, 
which was suggested by the high antibody levels in BTM, these results suggested a 
high probability of self-clearance.  
 
Self-clearance 
According to the results from the logistic regression model, the probability of self-
clearance was not associated with herd size or vaccination practices. Self-clearance 
is theoretically more likely to occur in smaller herds, but a generally higher herd 
biosecurity standard in the larger herds, and an increased risk for early death in PI 
animals  due  to  more  intensive  production  and  harder  rearing  conditions,  could 
possibly explain this result. Regarding vaccination, any effect  could be hard to 
detect,  because  the  number  of  farmers  that  used  BVDV  vaccines  was  limited. 
However,  it  was  noteworthy  that  among  the  seven  farmers  that  practiced 
vaccination  (using  the  same  inactivated  vaccine),  at  least  six  different  regimes 
were used, clearly reflecting the fact that vaccination in general is implemented on 
a herd-to-herd basis leaving the decision to the farmer or responsible veterinarian.  
 
BVDV and Neospora caninum infections and abortions (Paper III) 
Between January 2002 and March 2004, 1094 pregnancies were confirmed in 538 
cows. Of these, 137 pregnancies (13%) in 121 cows ended in abortion and 207 
cows were lost from follow-up. Of the abortions, 94 (69%) were registered after 
day 100 in gestation. The seroprevalences of Neospora caninum and BVDV in the 
group of animals tested at the initial screening were 47% and 97%, respectively. 
One heifer was identified as being persistently infected at the initial screening, and 
another three calves at the testing in January 2003. All PI animals were eliminated, 
and the herd was considered free from BVDV infection after the 1
st of April 2003.  
 
According to the survival analysis, current BVDV infection was not associated 
with the abortion problem in the herd. BVDV infections can cause abortion at any 
time during gestation, but only in dams not previously exposed to the infection 
(Grooms, 2004). Thus, in this study any effect of BVDV infection could only be 
expected in the group of susceptible animals. With a  BVDV seroprevalence of 
97% at the initial screening, the size of this group was too small to enable us to 
detect any effect.   
 
Neospora caninum infections, on the other hand, significantly affected the risk 
of abortions, but only those occurring after day 100 in gestation. The magnitude of 
the effect was most prominent in heifers, and decreased with parity. In heifers, the 
hazard of late abortion was >6-fold higher in infected animals compared to non-
infected.  In  first-lactation  and  multiparous  cows,  the  hazard  ratios  for  infected 
animals were 3.7 and 1.9, respectively. This observation, i.e. that the hazard of late 
abortions  associated  with  Neospora  caninum  infections  decreased  with  parity, 
suggested that protective maternal immunity to the parasite might increase with 
age.  
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Genetic diversity of BVDV (Paper IV) 
The phylogenetic analysis of 15 BVDV strains isolated from animals detected as 
PI during the studies in Arequipa and the Mantaro Valley, demonstrated that all 
belonged  to  genotype  1,  and  could  further  be  subdivided  into  subtype  1b.  In 
addition, it showed that strains circulating in Peru were genetically very similar to 
previously described strains from South America, USA and Europe. This was the 
first study of the genetic diversity of BVDV in Peru. Despite the limited number of 
strains included in the study, and despite the fact that most of the strains originated 
from Arequipa, a few interesting observations could be made. Several studies have 
addressed  the question of  the geographical distribution of BVDV genotypes or 
subtypes within a country, and in these a low regional variation has been found 
(Tajima  et  al.,  2001;  Hurtado  et  al.,  2003;  Mishra  et  al.,  2004).  This  lack  of 
variation is probably the result of uncontrolled livestock trade within a country and 
an efficient spread of prevalent strains. Thus, we could expect that our results were 
valid  also  for  the  other  major  dairy  regions  in  the  country.  According  to  the 
phylogenetic analysis all strains were BVDV-1b, the predominant BVDV subtype 
in many countries all over the world, including USA (Ridpath, 2005b). In spite of 
this, most vaccines on the market are produced with prototype BVDV-1a strains, 
sometimes  in  combination  with  BVDV-2  strains.  Four  BVDV  vaccines  are 
currently available in Peru; all are based on inactivated BVDV-1a , in one recently 
launched vaccine, in combination with an inactivated BVDV-2 strain. The genetic 
similarity  with  previously  described  strains  was  also  noteworthy,  and  clearly 
reflected the role of livestock trade for the diversity of BVDV. Imported livestock 
is  the  probable  source  of  BVDV  strains  circulating  in  the  country,  and  that  is 
supported by the phylogenetic analysis.  
 
Molecular epidemiology of BVDV in Sweden (Paper V) 
Between October 2002 and August 2005, more than 500  individuals from 130 
herds were identified as PI within the Swedish BVDV control programme. The 
5´NCR  of  at  least  one  isolate  from  each  of  these  infected  herds  have  been 
sequenced,  and  it  is  estimated  that  these  isolates  represent  >60%  of  all  strains 
circulating  in  the  country.  Phylogenetic  analysis  has  shown  that  all  Swedish 
BVDV strains belong to genotype 1, and that subtypes 1b (~25%) and 1d (>70%) 
are the most prevalent.  In a previous study from Sweden, Vilcek et al. (1999) 
demonstrated a strict herd-specific genetic clustering of  BVDV, i.e. that animals 
within a herd were infected with one specific strain. Moreover, they observed that 
isolates from each of the herds included in the study were unique for that herd, 
based on analysis of the 5´NCR. Our analysis confirmed the herd-specificity of 
BVDV (data not shown), but showed that, in many cases, isolates from different 
herds could not be distinguished based on this conserved region of the genome. In 
total, we could distinguish 73 different strains,  and among them 22 groups,  in 
which isolates from between 2 and 16 different herds shared 5´NCR sequences. 
We assumed that this genetic similarity was an indication of a connection between 
the  herds  of  origin.  The  results  were  compared  with  reports  on  suspected 
transmission  routes,  and  we  were  in  many  cases  able  to  confirm  or  rule  out 
suspicions. In this way we could also identify and prevent risky behaviour. 
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The  geographical  distribution  of  selected  BVDV-1d  strains,  suggested  as 
expected,  a  certain  clustering  of  genetically  similar  isolates,  with  one  clear 
exception. The strain, called 1d1, that had been isolated from 16 different herds 
was widely spread (Fig. 2a).   Phylogenetic analysis of the 5´NCR of the same 
selected strains indicated that strain 1d1 was the most probable common ancestor 
of the other strains (Fig. 2b). The geographical distribution of strain 1d1 and the 
phylogenetic  analysis  taken  together  suggested  that  a  large  portion  of  BVDV 
strains currently circulating in the country originate from one single introduction, 
possibly of a 1d1 strain. Thus, this strain has been circulating for many years and 
has been able to spread over the country.  
 
 
These results indicated that BVDV might circulate for many years and remain 
genetically  unaltered.  The  heterogeneity  of  BVDV  is  believed  to  be  due  to 
accumulation of mutations generated during acute rather than persistent infections 
because acute infections favour survival of viral variants that are able of escaping 
from the immune response (Bolin & Grooms, 2004). The selective pressure and 
the rate at which the virus mutates under Swedish conditions, however, seems to 
be  low.  A  low  cattle  density  with  restricted  livestock  movements  and  low 
prevalence  of  other  bovine  pathogens  might,  together  with  a  non-vaccination 
policy,  be  factors  that  have  contributed  to  a  low  selective  pressure  and  low 
mutation rate. This, however, is only a speculation. 
 
 
Neospora caninum in Arequipa (Paper II) 
The results from BTM testing in Arequipa demonstrated that 97% of the tested 
herds had been exposed to Neospora caninum, a very high level of exposure even 
in  an  international  comparison  (reviewed  in:  Dubey,  2003).  Possibly,  this  is  a 
result of the introduction of livestock from countries with high prevalence of the 
infection  such  as  USA,  Germany  and  the  Netherlands  (Bartels  et  al.,  2006). 
However,  it  also  suggests  a  high  rate  of  horizontal  spread  and  between-herd 
transmission in  the region. Dogs, which are known as  the main risk factor for 
horizontal spread, are present on most of the farms, and many are free roaming. 
Animals are kept outdoors, and, typically, nothing is done to prevent the access of 
dogs  to  the  cattle  area.  There,  they  may  get  infected  by  ingestion  of  naturally 
infected  placentas  or  aborted  foetuses,  and  then  transmit  the  infection  to  the 
susceptible cattle through faecal contamination of water or feed (De Marez et al., 
1999; Dijkstra et al., 2001). High cattle density may also have contributed to this 
situation  and  has  previously  been  shown  to  be  associated  with  high  Neospora 
caninum  prevalence  (Barling  et  al.,  2000).  In  addition,  a  few  studies  have 
indicated an impact of climatic factors (Schares et al., 2004; Rinaldi et al., 2005). 
Sporulation of oocysts is favoured by elevated temperatures, and it is speculated 
that  rapid  sporulation,  shortly  after  shedding,  might  increase  the  chance  of 
infecting cattle, if the contaminated feed or water is ingested immediately after 
contamination  (Schares,  et  al.,  2004).  If  so,  the  sunny  subtropical  climate  in 
Arequipa would be favourable, and would, consequently, contribute to a high rate 
of horizontal spread.  
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BHV-1 in the Mantaro Valley (Paper I) 
The results from the BTM testing in Mantaro demonstrated a moderate level of 
exposure  to  BHV-1,  and  approximately  half  of  the  herds  tested  positive.  This 
might indicate that the infection is circulating in the dairy population, and that it 
has  an  impact  on  production  and  reproductive  performance  in  affected  herds. 
However, latently infected animals remain seropositive for life, and, in small sized 
herds, even a single seropositive animal may result in the BTM becoming positive 
(Kampa, et al., 2004). Consequently, in smallholder dairy systems where animals 
are kept  longer and replacement rate  is  low,  BTM tests  may be positive many 
years after last exposure to the virus. In a recent study from Thailand, a herd level 
prevalence of BHV-1 of 67% was estimated, based on testing of BTM from 220 
dairy herds (Kampa, et al., 2004). However, when testing individual animals in a 
subset of 11 herds, it was demonstrated that none of the animals younger than four 
years had seroconverted to BHV-1. This suggested that the risk for reactivation of 
latent  BHV-1  infections  in  smallholder  dairy  systems  with  low-intensive 
production, is low, and indicated that progressive self-clearance might occur. It is 
not  unlikely  that  this  is  the  case  also  in  the  Mantaro  Valley.  Regarding  the 
situation in Arequipa, we tested 285 lactating animals in  the herd described in 
Paper III, for antibodies to BHV-1. In total, 30% of the animals tested positive. 
However, based on the distribution of COD values, it was evident that there had 
not been any virus circulation during the last four years (Fig. 3). This observation 
suggested that the risk for reactivation of latent BHV-1 might be low also in larger 
herds.  
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Figure 3. Distribution by age of BHV-1 corrected optical density values (COD) in milk, as 
measured in an indirect ELISA (SVANOVA Biotech, Uppsala, Sweden), from 285 cows in 
a dairy herd in Arequipa, Peru, 2002. Samples with COD≥0.2 were considered positive. 
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BVDV and reproductive performance (Papers II and III) 
Assessment of the impact on production and/or reproduction of endemic diseases 
is  important  for  the  motivation  of  farmers  as  well  as  authorities  to  establish 
measures to reduce prevalence and incidence of the diseases in question. However, 
even to achieve an estimate of the level of an individual producer requires reliable 
information. Smallholder dairy producers  in Peru  typically do not keep written 
records.  Consequently,  although  the  focus  of  this  project  was  the  situation  in 
smallholder dairy systems, we decided to perform the study described in Paper III 
in a  larger  commercial dairy farm. We believe  that there is no reason that  the 
results cannot be extrapolated to the smaller herds.  
 
Reproductive losses due to BVDV are typically most obvious during the first 
period after introduction of the infection into a naïve population. As the proportion 
of  immunized  animals  increases,  the  portion  of  animals  that  possibly  can  be 
affected decreases. The impact of the infection changes in nature, from mainly 
affecting reproduction to primarily affect calf health. Consequently, with a BVDV 
seroprevalence of 97% at the start of the study, it could be concluded that the high-
risk period for reproductive losses had already passed. However, during the study 
three  PI  calves  were  identified,  corresponding  to  approximately  0.75%  of  all 
calves born during the first year. Assuming a constant level of BVDV exposure to 
dams  from  insemination  and  throughout  gestation,  it  could  be  expected  that  a 
number  of  infections  also  resulted  in  failure  of  fertilization,  early  embryonic 
deaths, or birth of congenitally infected  calves that were  not considered  in the 
study. In an American study, it was demonstrated that, in endemically infected 
herds  with  a  prevalence  of  PI  calves  of  0.5%,  the  proportion  of  congenitally 
infected  calves  might  amount  to  10%  (Munoz-Zanzi,  et  al.,  2003).  These 
congenitally  infected  calves  might,  besides  an  increased  risk  of  experiencing 
serious postnatal health effects, also have lower fertility compared to non-infected 
individuals (Munoz-Zanzi, Thurmond & Hietala, 2004). Therefore, although we 
were unable to detect any association between BVDV and the endemic abortions 
in the studied herd, we can assume that reproduction as well as production was 
affected by the infection. Given the level of exposure in the dairy population in 
Arequipa  (Paper  II),  it  can  also  be  assumed  that  BVDV  affects  reproductive 
performance in the dairy population in general, and that the infection contributes to 
the reproductive failures that severely affect the smallholders in the region. 
 
Control 
A general model for BVDV control has been described (Lindberg & Houe, 2005), 
and should, theoretically, be applicable also in Peru, either on a national or on a 
regional scale, and it is beyond the scope of this project to form recommendations 
on  an  alternative  strategy.  However,  several  of  the  results  do  relate  to  BVDV 
control  in  general,  and  under  the  specific  circumstances  in  smallholder  dairy 
systems in Arequipa, in particular. 
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Vaccination 
Today in Arequipa, efforts aimed at controlling BVDV are restricted to the use of 
inactivated  vaccines,  typically  implemented  in  herds  affected  by  severe 
reproductive failures, to prevent abortions. However, in many cases the abortion 
problem continues, in spite of the implemented vaccination programme (Olivera, 
SENASA, personal communication). A few reasons for BVDV vaccine failures 
have  already  been  mentioned,  and  include  antigenic  differences  between  field 
strains and vaccine strains (Paper IV), and inconsistent use (Paper II). When it 
comes to prevention of abortions, however, other factors must also be considered. 
The  cause  of  abortions  is  in  many  cases  not  thoroughly  investigated,  and  the 
decision to vaccinate is, in general, based only on serological evidence of BVDV. 
Because BVDV seropositivity in individual animals is not an indication of ongoing 
infection,  but  of  long-lasting  immunity  after  previous  exposure,  a  serological 
response  cannot be used  to infer causality between BVDV and abortions. In a 
study from Brazil, the prevalence of Neospora caninum infections in dairy herds in 
which vaccination against BVDV and BHV-1 was used, was compared with that in 
non-vaccinated  herds  (de  Melo,  Leite  &  Lobato,  2004).  Vaccinated  herds  had 
serious abortion problems despite the use of vaccines, and it was observed that the 
prevalence of Neospora caninum in these herds were significantly higher than in 
the non-vaccinated herds. Although not mentioned by the authors, this strongly 
suggested  that  the  abortion  problems  were  associated  with  Neospora  caninum 
infections,  and  that  the  decisions  to  implement  vaccination  programmes  were 
based on incorrect diagnoses. Considering the high level of exposure to Neospora 
caninum in the dairy population (Papers II and III), it is likely that this could be the 
case also in Arequipa. However, massive vaccination of cows is questionable also 
in herds with reproductive losses caused by BVDV.  These herds are likely to have 
a high within-herd prevalence of seropositive cows, i.e. of cows with protective 
immunity after natural exposure. BVDV vaccination of immune animals is never 
economically justified, particularly not in regions with limited economic resources.  
 
In addition,  although all available  BVDV vaccines are inactivated,  the  most 
commonly used vaccine is multivalent and contains live virus components. The 
risk of spreading BVDV through contaminated vaccines should therefore also be 
considered (Barkema, et al., 2001).  
 
Biosecurity and virus elimination 
The  ability  to  prevent  introduction  of  BVDV  depends  mainly  on  the  level  of 
implemented  biosecurity  measures.  The  main  risk  factors  and  routes  of 
transmission  are  well  established,  and  can,  as  demonstrated  by  the  European 
BVDV control programmes, be reduced. However, this requires a high degree of 
involvement  and  awareness  of  farmers,  industry  and  authorities  (Lindberg  & 
Houe, 2005). By using molecular epidemiological tools (Paper IV and Paper V), 
biosecurity breaches and transmission routes can be identified, and the results can 
be  used  in  a  pedagogic  way  to  communicate  to  the  stakeholders,  the  possible 
outcome of insufficient biosecurity and risky behaviour.  
 
The importance of the PI animal for within-herd transmission and persistence is 
well established, and the process of identification and elimination of PI animals is   35 
required for systematic BVDV control. In Paper III, a BVDV infected herd was 
cleared from the infection through active intervention, i.e. through identification 
and elimination of PI animals, according to the principles described by Lindberg & 
Alenius  (1999).  Today,  three  years  later,  the  herd  remains  free.  However,  the 
results from Papers I and II, strongly suggest that many herds may be cleared from 
BVDV even without  intervention, and that a long-term reduction in prevalence 
probably  can  be  achieved  as  long  as  adequate  attention  is  given  to  systematic 
measures aimed at preventing re-introduction of infection.  
 
 
 
Concluding remarks 
•  The level of BVDV exposure in the studied population is very high in a 
national  and  international  comparison,  partly  explained  by  high  cattle 
density  and  uncontrolled  livestock  trade.  It  is  assumed  that  BVDV 
contributes  to  the  reproductive  disorders  that  severely  affect  the 
smallholders in the country. 
 
•  A large proportion of infected herds may be cleared from BVDV without 
intervention  even  in  regions  with  high  cattle  density,  high  BVDV 
prevalence,  and  regardless  of  vaccination  practices  and  herd  size. 
Consequently, self-clearance is a process that should be taken into account 
when a control programme is under consideration. 
 
•  BVDV strains circulating in Peru belong to genotype 1, and can further be 
subdivided  into  subtype  1b.  Peruvian  strains  are  genetically  similar  to 
previously  described  strains  from  South  America,  USA  and  Europe, 
reflecting the role of livestock trade for the diversity of BVDV. 
 
•  A  molecular  epidemiological  approach  may  be  used  to  trace  routes  of 
BVDV transmission, and to identify and prevent risky behaviour within a 
BVDV  control  programme.  A  single  introduction  of  BVDV  into  a 
susceptible population may result in widespread infection, and an introduced 
strain may circulate for many years and remain genetically unaltered.  
 
•  The level of exposure to Neospora caninum is high and the infection is an 
important  differential  diagnosis  to  BVDV  in  the  studied  population. 
Neospora caninum is associated with abortions occurring after day 100 in 
gestation in herds with endemic abortions. The magnitude of the effect of 
infection is most prominent in heifers and decreases with parity, suggesting 
that protective maternal immunity to the parasite may increase with age.  
 
•  The  level  of  exposure  to  BHV-1  in  the  studied  population  is  moderate. 
However, it is suggested that the risk of reactivation of latent infection is 
low. 
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